Smoking history can both increase the risk of cancer and create a hypoxic environment within the body, leading to poor outcomes, including less-effective treatment, among patients who undergo radiotherapy.
Being either a current or former smoker was linked to a greater likelihood of adverse outcomes following adjuvant radiotherapy (RT) for breast cancer, according to review results published in Cancer Treatment and Research Communications.
With there being plenty of evidence to link smoking history and both cancer risk and diagnosis, the authors of the present review focused on whether former and current cigarette smokers were also more likely to experience adverse outcomes following RT. They searched Ovid MEDLINE, Cochrane Central Register of Controlled Trials, and Embase Classic and Embase for studies published between 1947 and January 2019, using such keywords as breast cancer, cigarette smoking, radiotherapy, and outcomes.
Seventy-three articles were included in the authors’ review, which evaluated outcomes following adjuvant RT for breast cancer in current and former smokers. The authors divided these outcomes into 6 categories:
Overall, 198 outcomes were observed between the patients with a smoking history and never-smokers, and 41% were considered significant.
Of the 28 included studies that examined the association between smoking, RT, and skin reactions, skin toxicity was seen in 50% of the patients with a smoking history, which led to significantly worse outcomes after treatment (P < .05) compared with nonsmokers. Greater likelihoods of edema, telangiectasia, breast pain and sensitivity, pigmentation, and breast deformation were also reported.
Eight of the review studies looked at the influence of smoking history on breast reconstruction outcomes after RT. Six of these reported capsular contracture, reconstruction failure, and complications to be significant (P ≤ .05), with one also reporting a greater rate of major complications in smokers compared with nonsmokers (P = .003). A higher risk of tissue expander extrusion was associated (odds ratio [OR], 3.18) with smoking in another study.
The link between CV health and smoking history was evaluated, too, in 8 studies, with 3 reporting more CV events post RT in ever-smokers. However, one of these studies also showed a 2.2-times greater HR for adverse outcomes after RT when both CV health and smoking history (HR, 3.04; 95% CI, 2.03-4.55) were taken into account vs no smoking history (HR, 1.34; 95% CI, 0.94-1.91). Cardiotoxicity and left ventricular ejection fraction below 55% were also reported more often in smokers compared with nonsmokers.
Among the 15 articles reporting on pulmonary function changes, radiation pneumonitis was reported in 9, but this risk was not deemed significant. Meanwhile, RT-induced bronchiolitis obliterans were shown to be more common in patients who smoked (OR, 3.09; 95% CI, 1.01-9.48), and smokers were more likely to have “experienced the largest negative change in forced expiratory volume,” at —8.5% vs –4.6% in nonsmokers.
For the 11 articles in the review that examined secondary carcinomas, results from just 1 study showed a significantly higher risk of breast cancer recurrence compared with never smokers (HR, 6.69; P = .002). Having a smoking history was much more often associated with developing secondary lung cancer, and this risk was shown in one of the studies to be 1.7-times greater in patients who smoked 1 or more packs per day (OR, 46.91) vs those who smoked less than 1 pack (OR, 27.40)
Results from the 3 articles that examined mortality showed both a slightly higher risk of mortality for smokers vs nonsmokers (HR, 1.25; 95% CI, 1.06-1.47; P < .05) following RT, as well as a significant difference (HR, 1.11; 95% CI, 0.52-2.37, vs HR, 0.82; 95% CI, 0.42-1.61, respectively).
“None of the articles in this review reported better outcomes among smokers than never smokers,” the authors concluded. “Cigarette smoking can pose a higher risk of posttreatment complications that can influence an individual’s quality of life, survival rate, and/or recurrence risk. Whether patients who have a history of smoking or smoked during treatment are at similar risk of adverse events to patients who continue to smoke remains unclear.”
Emphasizing smoking cessation programs, informing patients of the potential risks associated with smoking, providing in-hospital patient education, and linking to care are all suggested as possible solutions for individuals to learn about the elevated risk for cancer and adverse treatment outcomes that may accompany their decision to smoke.
Reference
Wong G, Lam E, Karam I, et al. The impact of smoking on adjuvant breast cancer radiation treatment: a systematic review. Cancer Treat Res Commun. Published online June 20, 2020. doi:10.1016/j.ctarc.2020.100185
Metabolic Syndrome, Obesity Contribute to Breast Cancer Mortality in Postmenopausal Women
May 13th 2024A large study finds that obesity and metabolic syndrome raise breast cancer mortality risk, but through different mechanisms. Metabolic syndrome is linked to a specific type of breast cancer, whereas obesity increases risk across all breast cancer subtypes.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Social Equity, Strong Health Care Systems Can Improve Advanced Breast Cancer Outcomes Globally
May 6th 2024Disparities in health care systems around the world limit access to effective treatments for advanced breast cancer, especially for people in low- and middle-income countries and marginalized communities. Stronger health systems and social education efforts are necessary to improve outcomes for all patients.
Read More
The Disproportionate Impact of the Pandemic on Health Care Disparities and Cancer
February 22nd 2022On this episode of Managed Care Cast, we discuss how already wide health care inequities in cancer are becoming much worse because of the COVID-19 pandemic, with guest Monica Soni, MD, associate chief medical officer at New Century Health.
Listen
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More